Vertex Pharmaceuticals Inc (VRTX)

Return on assets (ROA)

		Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net income	US$ in thousands	3,619,600	3,322,000	2,342,100	2,711,700	1,176,800
Total assets	US$ in thousands	22,730,200	18,150,900	13,432,500	11,751,800	8,318,460
ROA		15.92%	18.30%	17.44%	23.07%	14.15%

December 31, 2023 calculation

ROA = Net income ÷ Total assets
= $3,619,600K ÷ $22,730,200K
= 15.92%

Vertex Pharmaceuticals, Inc.'s return on assets (ROA) has shown some fluctuations over the past five years. In 2023, the ROA was 15.92%, which was a decrease from the previous year's ROA of 18.30%. Despite this decrease, the company's ROA in 2023 was still relatively healthy compared to some prior years. In 2020, Vertex Pharmaceuticals had a notably higher ROA of 23.07%, indicating strong profitability relative to its total assets. The ROA in 2021 and 2019 were 17.44% and 14.15%, respectively. Overall, while there have been fluctuations, Vertex Pharmaceuticals has generally maintained a satisfactory level of return on its assets over the past five years.